No, tigecycline cannot be given orally (by mouth)
Tigecycline is only available as an intravenous (IV) formulation and must be administered through intravenous infusion. There is no oral formulation of tigecycline approved for clinical use 1.
Route of Administration
The FDA-approved drug label explicitly states that tigecycline is supplied as a powder for reconstitution and must be administered intravenously 1. The preparation involves:
- Reconstituting the powder with IV fluids (0.9% Sodium Chloride, 5% Dextrose, or Lactated Ringer's)
- Further diluting to achieve appropriate concentration (maximum 1 mg/mL in IV bag)
- Administering via IV infusion through a dedicated line or Y-site 1
Standard Dosing (IV Only)
The approved adult dosing regimen is:
- Loading dose: 100 mg IV
- Maintenance: 50 mg IV every 12 hours (q12h) 1
This twice-daily (q12h) intravenous dosing is consistent across all guidelines 2, 3. For severe infections, particularly those caused by multidrug-resistant organisms, some guidelines suggest high-dose regimens (loading dose 200 mg followed by 100 mg IV q12h) 4.
Why No Oral Formulation?
Tigecycline's pharmacokinetic properties make it unsuitable for oral administration in systemic infections. The drug has:
- Large volume of distribution with extensive tissue penetration
- Poor oral bioavailability for achieving therapeutic systemic concentrations
- Pharmacodynamics requiring specific serum and tissue levels (AUC/MIC ratios) that cannot be reliably achieved orally 5, 6
Important Clinical Caveats
Tigecycline carries an FDA boxed warning for increased all-cause mortality compared to other antibiotics 7, 1. The drug should be reserved for situations when alternative treatments are not suitable 1. Consultation with infectious disease specialists is recommended when considering tigecycline use 7.
The only exception where oral tigecycline has been studied is experimental research in animal models for Clostridium difficile infection 8, but this is not approved for human use and remains investigational.